Long-Term Impact of Cyclosporin Reduction with MMF Treatment in Chronic Allograft Dysfunction: REFERENECE Study 3-Year Follow Up

@inproceedings{Frimat2010LongTermIO,
  title={Long-Term Impact of Cyclosporin Reduction with MMF Treatment in Chronic Allograft Dysfunction: REFERENECE Study 3-Year Follow Up},
  author={Luc Frimat and Elisabeth Cassuto-Viguier and François Prov{\^o}t and Lionel P E Rostaing and Bernard Charpentier and K. Akposso and M. C. Moal and Philippe Lang and Denis Glotz and Sophie Caillard and Didier Ducloux and Claire Pouteil-Noble and Sandrine Girardot-Seguin and Mich{\`e}le Kessler},
  booktitle={Journal of transplantation},
  year={2010}
}
Calcineurin inhibitor (CNI) toxicity contributes to chronic allograft nephropathy (CAN). In the 2-year, randomized, study, we showed that 50% cyclosporin (CsA) reduction in combination with mycophenolate mofetil (MMF) treatment improves kidney function without increasing the risk for graft rejection/loss. To investigate the long-term effect of this regimen, we conducted a follow up study in 70 kidney transplant patients until 5 years after REFERENCE initiation. The improvement of kidney… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-6 of 6 extracted citations

Immunological risks of minimization strategies.

Transplant international : official journal of the European Society for Organ Transplantation • 2015
View 1 Excerpt

An evaluation of sirolimus in renal transplantation.

Expert opinion on drug metabolism & toxicology • 2012
View 1 Excerpt

Management of chronic allograft nephropathy.

Jornal brasileiro de nefrologia : 'orgao oficial de Sociedades Brasileira e Latino-Americana de Nefrologia • 2011

References

Publications referenced by this paper.
Showing 1-10 of 45 references

A 50% reduction in cyclosporine exposure in stable renal transplant recipients: renal function benefits.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association • 2010
View 1 Excerpt

A phase III study of belatacept-based immunosuppression regimens versus cyclosporine in renal transplant recipients (BENEFIT study).

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons • 2010
View 1 Excerpt

Preservation of renal function with everolimus and very low tacrolimus exposure in de novo renal transplant recipients at 12 months

J. Pascual, R. Hene
American Transplantation Congress, 2010, abstract 1633. • 2010
View 1 Excerpt

Calcineurin inhibitor nephrotoxicity.

Clinical journal of the American Society of Nephrology : CJASN • 2009

Nutritional and metabolic issues in solid organ transplantation: targets for future research.

Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation • 2009
View 1 Excerpt

Reduced exposure to calcineurin inhibitors in renal transplantation.

The New England journal of medicine • 2008
View 2 Excerpts

Similar Papers

Loading similar papers…